2连板翔宇医疗：截至2025年末脑机接口相关产品尚未实现规模化销售

Core Viewpoint - The company, Xiangyu Medical (688626.SH), has announced significant interest in brain engineering and brain-computer interface concepts in the capital market, leading to substantial stock price increases in related sectors [1] Group 1: Company Focus - The company is primarily focused on non-invasive brain-computer interface technology, which encompasses a comprehensive rehabilitation layout including occupational therapy, motor therapy, cognitive speech, and swallowing [1] - This approach differs from the current international trend towards invasive brain-computer interface technologies [1] Group 2: Market Position and Future Outlook - The company has made investments in brain-computer interface technology, establishing a certain level of layout in technology, products, and market channels [1] - However, the company faces challenges with bidding and sales processes that exhibit a lag, and as of the end of 2025, related products are not expected to achieve large-scale sales, resulting in a small proportion of revenue [1]